Fine-tuning gene scissors: Computer model for adjusting CRISPR-Cas9 enables more precise cuts in the genome

The CRISPR-Cas9 gene-editing tool makes it possible to modify the genetic material of organisms. But CRISPR technology is not perfect. Frequently, these molecular “scissors” also make incisions in genetic regions that have a similar appearance to the...


Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic





We welcome applications from young European start-up companies looking to expand their profile, advance their business ideas and build relationships with life-science investors and supporters of innovation.

European life-science spin-offs and...


Ausschreibung für ein Forschungsstipendium - Call for grant applications

Da die Bewerbung hierfür auf Englisch erfolgen muss, sind alle weiteren Informationen auf dieser Seite in Englischer Sprache verfasst.


The Challenge

ZNM – Zusammen Stark! e.V. – Research Grant Awards are designed to promote research in areas that...


ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule


ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.

Founded in 2016, Lava Therapeutics works on the development of antibody...


ProBioGen inks next Commercial GlymaxX® License with Roche

ADCC-enhancement for innovative cancer therapy


Studying the pancreas, cell by cell

Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin are coordinating an international project on the single-cell analysis of the human pancreas. The project is part of a global undertaking – known as the...


Make EU health research count!

Ahead of the European Council negotiations on the next Multiannual Financial Framework,academic and industry leaders supporting the LifeTime initiative, have called members of the European Union into action. They ask to preserve the existing Horizon...


Second Call for Proposals for Transnational Access Projects at EASI-Genomics

European Advanced infraStructure for Innovative Genomics


CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.

Accelerating new rare disease therapies through collaboration agreement

Show more items